Last but not least, taking into account the diverse facets of survivin expression in normal and neoplastic cells, it is nowadays capturing ample interest both as a prominent prognostic biomarker and as a potential cancer-targeted therapy[23]. This evidence concerns the gene BIRC5 and cancer.